The estimated Net Worth of Alexandar Jrraether Paul Er... is at least $253 millió dollars as of 16 March 2007. Alexandar Er owns over 24,501,505 units of Global X Funds stock worth over $50,016,633 and over the last 18 years Alexandar sold AIQ stock worth over $202,906,406.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Alexandar Er AIQ stock SEC Form 4 insiders trading
Alexandar has made over 2 trades of the Global X Funds stock since 2006, according to the Form 4 filled with the SEC. Most recently Alexandar sold 24,501,505 units of AIQ stock worth $153,134,406 on 16 March 2007.
The largest trade Alexandar's ever made was selling 24,501,505 units of Global X Funds stock on 16 March 2007 worth over $153,134,406. On average, Alexandar trades about 16,850,753 units every 54 days since 2006. As of 16 March 2007 Alexandar still owns at least 1,443,065 units of Global X Funds stock.
You can see the complete history of Alexandar Er stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Global X Funds
Over the last 21 years, insiders at Global X Funds have traded over $406,216,779 worth of Global X Funds stock and bought 11,973,300 units worth $47,156,496 . The most active insiders traders include Henry R Kravis, James H Jr Greene és Alexandar Jrraether Paul Er.... On average, Global X Funds executives and independent directors trade stock every 92 days with the average trade being worth of $57,648,557. The most recent stock trade was executed by Rhonda A Longmore Grund on 19 May 2016, trading 2,500 units of AIQ stock currently worth $18,975.
What does Global X Funds's logo look like?
Complete history of Alexandar Er stock trades at Global X Funds
Global X Funds executives and stock owners
Global X Funds executives and other stock owners filed with the SEC include:
-
R Brian Hanson,
Executive VP & CFO -
Russell D Jr Phillips,
EVP, Gen.Coun.,Secre. -
Henry R Kravis,
Director -
Kenneth S Ord,
Executive VP & CFO -
Rhonda A Longmore Grund,
EVP and CFO -
Heping Feng,
-
Tao L. Zhang,
-
Edward L Samek,
Director -
Richard A. Jones,
Executive Vice President -
Neil F Dimick,
Director -
Paul S Viviano,
Chairman, President & CEO -
Richard W Johns,
EVP, General Counsel & Sec. -
Percy C Jr Tomlinson,
President & CEO -
Gregory E. Spurlock,
President. Alliance Oncology -
Christianna S Rosow,
Principal Accounting Officer -
Scott A Bartos,
Director -
Larry C. Buckelew,
Director -
Howard K Aihara,
VP & Corporate Controller -
Deborah Rodriguez,
EVP, Human Resources -
Michael J Shea,
Chief Operating Officer -
Nicholas A Poan,
VP, Corporate Controller -
Eli H Glovinsky,
Exec.VP,Gen.Coun,Corp.Secre. -
Michael F Frisch,
Executive Vice President & COO -
Richard J Hall,
President, Alliance Oncology -
Curtis Lane,
Director -
Christopher J Joyce,
Executive Vice President, M&A -
Aaron Bendikson,
Director -
Health Investors Ii, Lp All...,
-
Anthony B Helfet,
Director -
Principal Opportunities Fun...,
-
Michael P Harmon,
Director -
Health Investors Ii, Lp All...,
-
Alexandar Jrraether Paul Er...,
-
James C Momtazee,
Director -
Michael W Michelson,
Director -
Kenneth W/Nj Freeman,
Director -
1996 Gp Llckkr Associates 1...,
-
James H Jr Greene,
Director -
Adam Clammer,
Director -
Andrew P Hayek,
Executive VP & COO